Search research articles
Contact Us
Filters
Showing results (241-250 of 256) with videos related to
Page
of 26
Sort By:
Nature Cancer
|
January 6, 2026
De novo H3.3K27M-altered diffuse midline glioma in human brainstem organoids to dissect GD2 CAR T cell function
Nils Bessler, Amber K L Wezenaar, Hendrikus C R Ariese, et al.
Bone Marrow Transplantation
|
April 15, 2020
Compatibility at amino acid position 98 of MICB reduces the incidence of graft-versus-host disease in conjunction with the CMV status
Raphael Carapito, Ismail Aouadi, Angélique Pichot, et al.
The Lancet. HIV
|
May 30, 2024
Dynamics of virological and immunological markers of HIV persistence after allogeneic haematopoietic stem-cell transplantation in the IciStem cohort: a prospective observational cohort study
Maria Salgado, Cristina Gálvez, Monique Nijhuis, et al.
Cytotherapy
|
November 11, 2025
Call for preserving specialized knowledge and contributions of the CAT to advancing ATMPs in Europe
Delphine Ammar, Carmen Sanges, David Henderson, et al.
Eclinicalmedicine
|
June 19, 2026
Fertility management and outcomes after CAR T-cell therapy: an international survey from the Cellular Therapy and Immunobiology working party of the European Society for Blood and Marrow Transplantation
Giorgio Orofino, Isabel Sánchez-Ortega, Juana Schwartz Mota, et al.
NPJ Digital Medicine
|
August 1, 2025
Design specifications for biomedical virtual twins in engineered adoptive cellular immunotherapies
Ulrike Weirauch, Markus Kreuz, Colin Birkenbihl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 25, 2013
High prognostic impact of flow cytometric minimal residual disease detection in acute myeloid leukemia: data from the HOVON/SAKK AML 42A study
Monique Terwijn, Wim L J van Putten, Angèle Kelder, et al.
Nature Biotechnology
|
July 25, 2022
Uncovering the mode of action of engineered T cells in patient cancer organoids
Johanna F Dekkers, Maria Alieva, Astrid Cleven, et al.
Leukemia
|
August 1, 2015
Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey
R Zeiser, A Burchert, C Lengerke, et al.
Cancers
|
February 10, 2021
Inferior Outcome of Addition of the Aminopeptidase Inhibitor Tosedostat to Standard Intensive Treatment for Elderly Patients with AML and High Risk MDS
Jeroen Janssen, Bob Löwenberg, Markus Manz, et al.
Page
of 26
Search research articles
Search
Showing results (241-250 of 256) with videos related to
Sort By:
Page
of 26
Nature Cancer
|
January 6, 2026
De novo H3.3K27M-altered diffuse midline glioma in human brainstem organoids to dissect GD2 CAR T cell function
Nils Bessler, Amber K L Wezenaar, Hendrikus C R Ariese, et al.
Bone Marrow Transplantation
|
April 15, 2020
Compatibility at amino acid position 98 of MICB reduces the incidence of graft-versus-host disease in conjunction with the CMV status
Raphael Carapito, Ismail Aouadi, Angélique Pichot, et al.
The Lancet. HIV
|
May 30, 2024
Dynamics of virological and immunological markers of HIV persistence after allogeneic haematopoietic stem-cell transplantation in the IciStem cohort: a prospective observational cohort study
Maria Salgado, Cristina Gálvez, Monique Nijhuis, et al.
Cytotherapy
|
November 11, 2025
Call for preserving specialized knowledge and contributions of the CAT to advancing ATMPs in Europe
Delphine Ammar, Carmen Sanges, David Henderson, et al.
Eclinicalmedicine
|
June 19, 2026
Fertility management and outcomes after CAR T-cell therapy: an international survey from the Cellular Therapy and Immunobiology working party of the European Society for Blood and Marrow Transplantation
Giorgio Orofino, Isabel Sánchez-Ortega, Juana Schwartz Mota, et al.
NPJ Digital Medicine
|
August 1, 2025
Design specifications for biomedical virtual twins in engineered adoptive cellular immunotherapies
Ulrike Weirauch, Markus Kreuz, Colin Birkenbihl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 25, 2013
High prognostic impact of flow cytometric minimal residual disease detection in acute myeloid leukemia: data from the HOVON/SAKK AML 42A study
Monique Terwijn, Wim L J van Putten, Angèle Kelder, et al.
Nature Biotechnology
|
July 25, 2022
Uncovering the mode of action of engineered T cells in patient cancer organoids
Johanna F Dekkers, Maria Alieva, Astrid Cleven, et al.
Leukemia
|
August 1, 2015
Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey
R Zeiser, A Burchert, C Lengerke, et al.
Cancers
|
February 10, 2021
Inferior Outcome of Addition of the Aminopeptidase Inhibitor Tosedostat to Standard Intensive Treatment for Elderly Patients with AML and High Risk MDS
Jeroen Janssen, Bob Löwenberg, Markus Manz, et al.
Page
of 26